Regarding the subject, important factors are the family and personal history of acquired (particularly associated with surgery) or hereditary bleeding disorders, comorbidities, concomitant medications, and laboratory tests such as platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), renal and liver function should be considered [14]. This evidence concerns the gene F2 and hemorrhagic disease.